Global and United States Demerol (Meperidine) Market Insights, Forecast to 2026

    • ID: AR2971916
    • 06 October, 2020
    • Other
    • Region: Global
    • 134 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Demerol (Meperidine) Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Demerol (Meperidine) Manufacturers Covered: Ranking by Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Demerol (Meperidine) Market Size Growth Rate by Type
      • 1.4.2 Powder
      • 1.4.3 Liquid
    • 1.5 Market by Application
      • 1.5.1 Global Demerol (Meperidine) Market Size Growth Rate by Application
      • 1.5.2 Anesthesia
      • 1.5.3 Cough Treatment
      • 1.5.4 Diarrhea Treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Demerol (Meperidine) Market Size, Estimates and Forecasts
      • 2.1.1 Global Demerol (Meperidine) Revenue 2015-2026
      • 2.1.2 Global Demerol (Meperidine) Sales 2015-2026
    • 2.2 Global Demerol (Meperidine), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.3 Demerol (Meperidine) Historical Market Size by Region (2015-2020)
      • 2.3.1 Global Demerol (Meperidine) Retrospective Market Scenario in Sales by Region: 2015-2020
      • 2.3.2 Global Demerol (Meperidine) Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 2.4 Demerol (Meperidine) Market Estimates and Projections by Region (2021-2026)
      • 2.4.1 Global Demerol (Meperidine) Sales Forecast by Region (2021-2026)
      • 2.4.2 Global Demerol (Meperidine) Revenue Forecast by Region (2021-2026)

    3 Global Demerol (Meperidine) Competitor Landscape by Players

    • 3.1 Global Top Demerol (Meperidine) Sales by Manufacturers
      • 3.1.1 Global Demerol (Meperidine) Sales by Manufacturers (2015-2020)
      • 3.1.2 Global Demerol (Meperidine) Sales Market Share by Manufacturers (2015-2020)
    • 3.2 Global Demerol (Meperidine) Manufacturers by Revenue
      • 3.2.1 Global Demerol (Meperidine) Revenue by Manufacturers (2015-2020)
      • 3.2.2 Global Demerol (Meperidine) Revenue Share by Manufacturers (2015-2020)
      • 3.2.3 Global Demerol (Meperidine) Market Concentration Ratio (CR5 and HHI) (2015-2020)
      • 3.2.4 Global Top 10 and Top 5 Companies by Demerol (Meperidine) Revenue in 2019
      • 3.2.5 Global Demerol (Meperidine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Global Demerol (Meperidine) Price by Manufacturers
    • 3.4 Global Demerol (Meperidine) Manufacturing Base Distribution, Product Types
      • 3.4.1 Demerol (Meperidine) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Demerol (Meperidine) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Demerol (Meperidine) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Demerol (Meperidine) Market Size by Type (2015-2020)
      • 4.1.1 Global Demerol (Meperidine) Sales by Type (2015-2020)
      • 4.1.2 Global Demerol (Meperidine) Revenue by Type (2015-2020)
      • 4.1.3 Demerol (Meperidine) Average Selling Price (ASP) by Type (2015-2026)
    • 4.2 Global Demerol (Meperidine) Market Size Forecast by Type (2021-2026)
      • 4.2.1 Global Demerol (Meperidine) Sales Forecast by Type (2021-2026)
      • 4.2.2 Global Demerol (Meperidine) Revenue Forecast by Type (2021-2026)
      • 4.2.3 Demerol (Meperidine) Average Selling Price (ASP) Forecast by Type (2021-2026)
    • 4.3 Global Demerol (Meperidine) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Market Size by Application (2015-2026)

    • 5.1 Global Demerol (Meperidine) Market Size by Application (2015-2020)
      • 5.1.1 Global Demerol (Meperidine) Sales by Application (2015-2020)
      • 5.1.2 Global Demerol (Meperidine) Revenue by Application (2015-2020)
      • 5.1.3 Demerol (Meperidine) Price by Application (2015-2020)
    • 5.2 Demerol (Meperidine) Market Size Forecast by Application (2021-2026)
      • 5.2.1 Global Demerol (Meperidine) Sales Forecast by Application (2021-2026)
      • 5.2.2 Global Demerol (Meperidine) Revenue Forecast by Application (2021-2026)
      • 5.2.3 Global Demerol (Meperidine) Price Forecast by Application (2021-2026)

    6 United States by Players, Type and Application

    • 6.1 United States Demerol (Meperidine) Market Size YoY Growth 2015-2026
      • 6.1.1 United States Demerol (Meperidine) Sales YoY Growth 2015-2026
      • 6.1.2 United States Demerol (Meperidine) Revenue YoY Growth 2015-2026
      • 6.1.3 United States Demerol (Meperidine) Market Share in Global Market 2015-2026
    • 6.2 United States Demerol (Meperidine) Market Size by Players (International and Local Players)
      • 6.2.1 United States Top Demerol (Meperidine) Players by Sales (2015-2020)
      • 6.2.2 United States Top Demerol (Meperidine) Players by Revenue (2015-2020)
    • 6.3 United States Demerol (Meperidine) Historic Market Review by Type (2015-2020)
      • 6.3.1 United States Demerol (Meperidine) Sales Market Share by Type (2015-2020)
      • 6.3.2 United States Demerol (Meperidine) Revenue Market Share by Type (2015-2020)
      • 6.3.3 United States Demerol (Meperidine) Price by Type (2015-2020)
    • 6.4 United States Demerol (Meperidine) Market Estimates and Forecasts by Type (2021-2026)
      • 6.4.1 United States Demerol (Meperidine) Sales Forecast by Type (2021-2026)
      • 6.4.2 United States Demerol (Meperidine) Revenue Forecast by Type (2021-2026)
      • 6.4.3 United States Demerol (Meperidine) Price Forecast by Type (2021-2026)
    • 6.5 United States Demerol (Meperidine) Historic Market Review by Application (2015-2020)
      • 6.5.1 United States Demerol (Meperidine) Sales Market Share by Application (2015-2020)
      • 6.5.2 United States Demerol (Meperidine) Revenue Market Share by Application (2015-2020)
      • 6.5.3 United States Demerol (Meperidine) Price by Application (2015-2020)
    • 6.6 United States Demerol (Meperidine) Market Estimates and Forecasts by Application (2021-2026)
      • 6.6.1 United States Demerol (Meperidine) Sales Forecast by Application (2021-2026)
      • 6.6.2 United States Demerol (Meperidine) Revenue Forecast by Application (2021-2026)
      • 6.6.3 United States Demerol (Meperidine) Price Forecast by Application (2021-2026)

    7 North America

    • 7.1 North America Demerol (Meperidine) Market Size YoY Growth 2015-2026
    • 7.2 North America Demerol (Meperidine) Market Facts & Figures by Country
      • 7.2.1 North America Demerol (Meperidine) Sales by Country (2015-2020)
      • 7.2.2 North America Demerol (Meperidine) Revenue by Country (2015-2020)
      • 7.2.3 U.S.
      • 7.2.4 Canada

    8 Europe

    • 8.1 Europe Demerol (Meperidine) Market Size YoY Growth 2015-2026
    • 8.2 Europe Demerol (Meperidine) Market Facts & Figures by Country
      • 8.2.1 Europe Demerol (Meperidine) Sales by Country
      • 8.2.2 Europe Demerol (Meperidine) Revenue by Country
      • 8.2.3 Germany
      • 8.2.4 France
      • 8.2.5 U.K.
      • 8.2.6 Italy
      • 8.2.7 Russia

    9 Asia Pacific

    • 9.1 Asia Pacific Demerol (Meperidine) Market Size YoY Growth 2015-2026
    • 9.2 Asia Pacific Demerol (Meperidine) Market Facts & Figures by Country
      • 9.2.1 Asia Pacific Demerol (Meperidine) Sales by Region (2015-2020)
      • 9.2.2 Asia Pacific Demerol (Meperidine) Revenue by Region
      • 9.2.3 China
      • 9.2.4 Japan
      • 9.2.5 South Korea
      • 9.2.6 India
      • 9.2.7 Australia
      • 9.2.8 Taiwan
      • 9.2.9 Indonesia
      • 9.2.10 Thailand
      • 9.2.11 Malaysia
      • 9.2.12 Philippines
      • 9.2.13 Vietnam

    10 Latin America

    • 10.1 Latin America Demerol (Meperidine) Market Size YoY Growth 2015-2026
    • 10.2 Latin America Demerol (Meperidine) Market Facts & Figures by Country
      • 10.2.1 Latin America Demerol (Meperidine) Sales by Country
      • 10.2.2 Latin America Demerol (Meperidine) Revenue by Country
      • 10.2.3 Mexico
      • 10.2.4 Brazil
      • 10.2.5 Argentina

    11 Middle East and Africa

    • 11.1 Middle East and Africa Demerol (Meperidine) Market Size YoY Growth 2015-2026
    • 11.2 Middle East and Africa Demerol (Meperidine) Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Demerol (Meperidine) Sales by Country
      • 11.2.2 Middle East and Africa Demerol (Meperidine) Revenue by Country
      • 11.2.3 Turkey
      • 11.2.4 Saudi Arabia
      • 11.2.5 U.A.E

    12 Company Profiles

    • 12.1 Purdue Pharma
      • 12.1.1 Purdue Pharma Corporation Information
      • 12.1.2 Purdue Pharma Description and Business Overview
      • 12.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
      • 12.1.4 Purdue Pharma Demerol (Meperidine) Products Offered
      • 12.1.5 Purdue Pharma Recent Development
    • 12.2 Egalet
      • 12.2.1 Egalet Corporation Information
      • 12.2.2 Egalet Description and Business Overview
      • 12.2.3 Egalet Sales, Revenue and Gross Margin (2015-2020)
      • 12.2.4 Egalet Demerol (Meperidine) Products Offered
      • 12.2.5 Egalet Recent Development
    • 12.3 Boehringer Ingelheim
      • 12.3.1 Boehringer Ingelheim Corporation Information
      • 12.3.2 Boehringer Ingelheim Description and Business Overview
      • 12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
      • 12.3.4 Boehringer Ingelheim Demerol (Meperidine) Products Offered
      • 12.3.5 Boehringer Ingelheim Recent Development
    • 12.4 Janssen
      • 12.4.1 Janssen Corporation Information
      • 12.4.2 Janssen Description and Business Overview
      • 12.4.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
      • 12.4.4 Janssen Demerol (Meperidine) Products Offered
      • 12.4.5 Janssen Recent Development
    • 12.5 Sanofi
      • 12.5.1 Sanofi Corporation Information
      • 12.5.2 Sanofi Description and Business Overview
      • 12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
      • 12.5.4 Sanofi Demerol (Meperidine) Products Offered
      • 12.5.5 Sanofi Recent Development
    • 12.6 Sun Pharmaceuticals
      • 12.6.1 Sun Pharmaceuticals Corporation Information
      • 12.6.2 Sun Pharmaceuticals Description and Business Overview
      • 12.6.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
      • 12.6.4 Sun Pharmaceuticals Demerol (Meperidine) Products Offered
      • 12.6.5 Sun Pharmaceuticals Recent Development
    • 12.7 Mallinckrodt Pharmaceuticals
      • 12.7.1 Mallinckrodt Pharmaceuticals Corporation Information
      • 12.7.2 Mallinckrodt Pharmaceuticals Description and Business Overview
      • 12.7.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
      • 12.7.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Products Offered
      • 12.7.5 Mallinckrodt Pharmaceuticals Recent Development
    • 12.8 Endo Pharmaceuticals
      • 12.8.1 Endo Pharmaceuticals Corporation Information
      • 12.8.2 Endo Pharmaceuticals Description and Business Overview
      • 12.8.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
      • 12.8.4 Endo Pharmaceuticals Demerol (Meperidine) Products Offered
      • 12.8.5 Endo Pharmaceuticals Recent Development
    • 12.9 Actavis
      • 12.9.1 Actavis Corporation Information
      • 12.9.2 Actavis Description and Business Overview
      • 12.9.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
      • 12.9.4 Actavis Demerol (Meperidine) Products Offered
      • 12.9.5 Actavis Recent Development
    • 12.10 Pfizer
      • 12.10.1 Pfizer Corporation Information
      • 12.10.2 Pfizer Description and Business Overview
      • 12.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
      • 12.10.4 Pfizer Demerol (Meperidine) Products Offered
      • 12.10.5 Pfizer Recent Development
    • 12.11 Purdue Pharma
      • 12.11.1 Purdue Pharma Corporation Information
      • 12.11.2 Purdue Pharma Description and Business Overview
      • 12.11.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
      • 12.11.4 Purdue Pharma Demerol (Meperidine) Products Offered
      • 12.11.5 Purdue Pharma Recent Development

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Porter’s Five Forces Analysis
    • 13.5 Primary Interviews with Key Demerol (Meperidine) Players (Opinion Leaders)

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Demerol (Meperidine) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Demerol (Meperidine) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Demerol (Meperidine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      Segment by Type, the Demerol (Meperidine) market is segmented into
      Powder
      Liquid

      Segment by Application, the Demerol (Meperidine) market is segmented into
      Anesthesia
      Cough Treatment
      Diarrhea Treatment

      Regional and Country-level Analysis
      The Demerol (Meperidine) market is analysed and market size information is provided by regions (countries).
      The key regions covered in the Demerol (Meperidine) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
      The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

      Competitive Landscape and Demerol (Meperidine) Market Share Analysis
      Demerol (Meperidine) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Demerol (Meperidine) business, the date to enter into the Demerol (Meperidine) market, Demerol (Meperidine) product introduction, recent developments, etc.
      The major vendors covered:
      Purdue Pharma
      Egalet
      Boehringer Ingelheim
      Janssen
      Sanofi
      Sun Pharmaceuticals
      Mallinckrodt Pharmaceuticals
      Endo Pharmaceuticals
      Actavis
      Pfizer



      Summary:
      Demerol (Meperidine) Market Research Report is about Demerol (Meperidine) Industry study. Get complete Demerol (Meperidine) market research report published after Market Study, Industrial Analysis with Trends & Statistics. Demerol (Meperidine) Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $3,900.00
      $3,900.00
      $3,900.00